1. Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial. Issue 9 (8th September 2017) Authors: Nakase, H.; Motoya, S.; Matsumoto, T.; Watanabe, K.; Hisamatsu, T.; Yoshimura, N.; Ishida, T.; Kato, S.; Nakagawa, T.; Esaki, M.; Nagahori, M.; Matsui, T.; Naito, Y.; Kanai, T.; Suzuki, Y.; Nojima, M.; Watanabe, M.; Hibi, T. Other Names: Andoh Akira investigator.; Ashida Toshifumi investigator.; Endo Katsuya investigator.; Endo Yutaka investigator.; Esaki Motohiro investigator.; Fujita Hiroshi investigator.; Fujiya Mikihiro investigator.; Haruma Ken investigator.; Hibi Toshifumi investigator.; Hiraoka Sakiko investigator.; Hirata... Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 9(2017) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗